TXN vs XBIO · P/E 52, rev $10.29B vs rev $1.5M
Texas Instruments Incorporated (TXN) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.
TXN currently screens at market cap $274.74B and trailing P/E 51.7. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the TXN and XBIO stock pages for the full models.
Not investment advice.